| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 5968 | 2020 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1755 | 2021 |
| Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients A Jayk Bernal, MM Gomes da Silva, DB Musungaie, E Kovalchuk, ... New England Journal of Medicine 386 (6), 509-520, 2022 | 1640 | 2022 |
| Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study G Habib, PA Erba, B Iung, E Donal, B Cosyns, C Laroche, BA Popescu, ... European heart journal 40 (39), 3222-3232, 2019 | 577 | 2019 |
| A neutralizing monoclonal antibody for hospitalized patients with Covid-19 Activ-3/Tico Ly-CoV555 Study Group New England Journal of Medicine 384 (10), 905-914, 2021 | 328 | 2021 |
| A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19 O Mitjà, M Corbacho-Monné, M Ubals, A Alemany, C Suñer, C Tebé, ... New England Journal of Medicine 384 (5), 417-427, 2021 | 286 | 2021 |
| Randomized trial of molnupiravir or placebo in patients hospitalized with Covid-19 JR Arribas, S Bhagani, SM Lobo, I Khaertynova, L Mateu, R Fishchuk, ... NEJM evidence 1 (2), EVIDoa2100044, 2022 | 113 | 2022 |
| Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes E Pradenas, B Trinité, V Urrea, S Marfil, C Ávila-Nieto, ... Med 2 (3), 313-320. e4, 2021 | 105 | 2021 |
| SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity B Trinité, F Tarrés-Freixas, J Rodon, E Pradenas, V Urrea, S Marfil, ... Scientific Reports 11 (1), 2608, 2021 | 97 | 2021 |
| Inappropriate sinus tachycardia in post-COVID-19 syndrome J Aranyó, V Bazan, G Lladós, MJ Dominguez, F Bisbal, M Massanella, ... Scientific reports 12 (1), 298, 2022 | 80 | 2022 |
| The esc-eorp euro-endo (european infective endocarditis) registry G Habib, P Lancellotti, PA Erba, A Sadeghpour, M Meshaal, A Sambola, ... European Heart Journal-Quality of Care and Clinical Outcomes 5 (3), 202-207, 2019 | 77 | 2019 |
| Community‐Acquired Legionella Pneumonia in Elderly Patients: Characteristics and Outcome N Sopena, L Pedro‐Botet, L Mateu, G Tolschinsky, C Rey‐Joly, M Sabrià Journal of the American Geriatrics Society 55 (1), 114-119, 2007 | 55 | 2007 |
| Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: A randomised, double-blind, phase 3 trial TL Holland, AA Ginde, R Paredes, TA Murray, N Engen, G Grandits, ... The Lancet Respiratory Medicine 10 (10), 972-984, 2022 | 53 | 2022 |
| Identification of plitidepsin as potent inhibitor of SARS-CoV-2-induced cytopathic effect after a drug repurposing screen J Rodon, J Muñoz-Basagoiti, D Perez-Zsolt, M Noguera-Julian, ... Frontiers in pharmacology 12, 646676, 2021 | 48 | 2021 |
| Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial MN Polizzotto, J Nordwall, AG Babiker, A Phillips, DM Vock, N Eriobu, ... The Lancet 399 (10324), 530-540, 2022 | 41 | 2022 |
| A multicentre analysis of Nocardia pneumonia in Spain: 2010–2016 M Ercibengoa, J Càmara, F Tubau, D García-Somoza, A Galar, ... International Journal of Infectious Diseases 90, 161-166, 2020 | 38 | 2020 |
| Long COVID-19 and microvascular disease-related angina NV Camazón, A Teis, MJM Membrive, C Llibre, A Bayés-Genís, L Mateu Revista espanola de cardiologia (English ed.) 75 (5), 444, 2022 | 28 | 2022 |
| Streptococcus pneumoniae and Legionella pneumophila pneumonia in HIV-infected patients M Luisa Pedro-Botet, N Sopena, A García-Cruz, L Mateu, M García-Núñez, ... Scandinavian journal of infectious diseases 39 (2), 122-128, 2007 | 28 | 2007 |
| Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain A Roso-Llorach, X Serra-Picamal, FX Cos, M Pallejà-Millán, L Mateu, ... Global epidemiology 4, 100071, 2022 | 27 | 2022 |
| Persistent chest pain after recovery of COVID-19: microvascular disease-related angina? N Vallejo, A Teis, L Mateu, A Bayés-Genís European Heart Journal-Case Reports 5 (3), ytab105, 2021 | 23 | 2021 |
